SMTL ID : 6ylc.3 (3 other biounits)

Biochemical, Cellular and Structural Characterization of Novel ERK3 Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.43 Å

Oligo State

monomer

Ligands

1 x OXW: 5-fluoranyl-2-[5-[[1-(1-methylpiperidin-4-yl)pyrazol-4-yl]amino]-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]benzenecarbonitrile(Non-covalent)

OXW.1: 14 residues within 4Å: Chain A: L.18, N.23, V.26, A.39, K.41, Q.100, E.101, Y.102, M.103, E.104, T.105, D.106, F.151, D.163 8 PLIP interactions: 8 interactions with chain A Hydrophobic interactions: A:V.26, A:V.26, A:F.151 Hydrogen bonds: A:K.41, A:Q.100, A:M.103, A:M.103 Salt bridges: A:D.106

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Gradler, U. et al., Biochemical, cellular and structural characterization of novel and selective ERK3 inhibitors. Bioorg.Med.Chem.Lett. (2020)

Release Date

2020-09-23

Peptides

Mitogen-activated protein kinase 6: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

Mitogen-activated protein kinase 6

Related Entries With Identical Sequence